INMUNE BIO INC. Operating Lease, Payments
INMUNE BIO INC. (INMB) reported Operating Lease, Payments of $152.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-10-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-30
- INMUNE BIO INC. operating lease, payments for the quarter ending 2025-06-30 was $152.00K.
- INMUNE BIO INC. operating lease, payments for the quarter ending 2025-03-31 was $76.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | $152.00K 10-Q · filed 2025-10-30 | $152.00K 10-K · filed 2026-03-30 | $154.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $76.00K 10-K · filed 2026-03-30 | $77.00K 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |